4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-26-011159
Options or other derivatives
- Chief Executive Officer acquired 503,937 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-19 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +503,937 | 503,937 | D |
Loading xslF345X05/wk-form4_1771969496.xml…